Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03173521Phase 1/2Completed
Gene Therapy in Patients With Mucopolysaccharidosis Disease
Mucopolysaccharidosis Type VI
PrincipalinvestigatorStart date: 2017-07-17

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Department of Translational Medicine (DISMET) of "Federico II" University, Naples

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Celeste Decker, MD

BioMarin Pharmaceutical

Moderately Similar
4 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Lynda Polgreen, MD

The Lundquist Institute at Harbor-UCLA Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Chester B. Whitley, M.D., Ph.D.

University of Minnesota

Moderately Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Stuart J Sweidler, MD, Ph.D.

BioMarin Pharmaceutical

Moderately Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Tippi C MacKenzie, MD

University of California, San Francisco

Moderately Similar
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Richard Curtis Rogers, MD

Greenwood Genetic Center

Moderately Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

K. Scott Baker

Fairview University Medical Center

Moderately Similar
3 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Lynda E Polgreen, MD, MS

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Moderately Similar
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Thomas JA Lehman, MD

Chief, Division of Pediatric Rheumatology, Hospital for Special Surgery; Professor of Clinical Pediatrics, Cornell University

Moderately Similar
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Mitchell S Cairo, MD

New York Medical College

Moderately Similar
13 trials

Shared therapeutic areas:

Mucopolysaccharidosis VI
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03173521Phase 1/2PrincipalInvestigator

Gene Therapy in Patients With Mucopolysaccharidosis Disease

Mucopolysaccharidosis Type VI
Completed

All 1 trials loaded